Skip to main content
. Author manuscript; available in PMC: 2015 Dec 11.
Published in final edited form as: Eur Urol. 2013 Oct 26;65(2):267–269. doi: 10.1016/j.eururo.2013.10.016

Fig. 1.

Fig. 1

Bacillus Calmette-Guérin (BCG) maintenance is not created equal. (a–c) The left panel depicts Kaplan-Meier curves reflecting recurrence trends in three clinical trials showing no difference between BCG induction alone compared with BCG maintenance (suboptimal schedule) [7–9]. (d) The right panel depicts Kaplan-Meier curves reflecting the importance of true maintenance therapy for tumor recurrence in superficial bladder cancer of all stages [5]. BCG = bacillus Calmette-Guérin; CIS = carcinoma in situ; I = induction; M = maintenance.